What happens when a sex therapist visits a women-only Parkinson’s support group? A frank exchange about “redefining sexuality”, recalls Sharon Krischer AKA ‘Twitchy Woman’
Recently, psychologist and certified sex therapist, Dr Beth Leedham, spoke to our women’s support group about sex. A women-only environment allowed for an honest discussion about issues relating to Parkinson’s and our sexual behaviour.
According to Dr Leedham, most doctors and therapists are not comfortable about talking about it, and their patients are not comfortable talking about it, so no one talks about it.
There is very little research about women with Parkinson’s and sexuality. She started with an old survey, from 1992. The question was: “Over the last 12 months have you…?”
And the results: 43% of women and 31% of men reported having sexual dysfunction. The rate is higher in populations with mental or physical health issues. So this is a very common issue among all adults.
In a study of women with Parkinson’s, the most common difficulty is getting aroused (*87.5%). Parkinson’s affects the autonomic nervous system, and that is the system responsible for arousal. Others include difficulty reaching orgasm (75%) and dyspareunia or painful sex (12.5%).
Some of the causes: motor changes, bladder changes, cognitive changes, differences communicating emotion, sleep disturbance, depression, changes in self-esteem and body image, medication side effects and on and on.
“Most doctors and therapists are not comfortable about talking about it”
Sexuality statistics (Taken from a study in 1992)
43% of women and 31% of men with Parkinson’s reported experiencing sexual dysfunction
87.5% of women with Parkinson’s have difficulty is getting aroused Parkinson’s
75% have difficulty reaching orgasm
12.5% experience dyspareunia or painful intercourse
Was it “meh” for you too?
In addition, the normal issues related to aging can cause problems. Decrease of oestrogen and testosterone with menopause, vaginal tissues become thinner, decrease in lubrication. Men have aging issues too. So sexual dysfunction increases among all men and women as they age. The prevalence of sexual dysfunction among women with Parkinson’s is slightly higher than that of post-menopausal women. So is the problem due to aging or is it due to Parkinson’s?
In many cases changes in long-term relationships because of the condition can cause conflicts for both the person with Parkinson’s and the partner. Sometimes, the partner experiences ‘well-spouse’ stress. ‘Enmeshment’, or unwelcome intimacies (closeness that is too close) can occur after a diagnosis. The well spouse may feel solely responsible for the partner with Parkinson’s.
The number one issue, however, is differences in desire between the two partners. Some of the issues are due to the aging of both partners, some are because of Parkinson’s and some are because of differences in expectations. We forget that we are not 20 years old anymore and that we experience things differently now. It is ok to negotiate and change things. Fix the causes that can be fixed.
Accommodate for aging. Address relationship issues. Take risks and try new things. Look at it as an opportunity to redefine and reclaim sexuality and eroticism.
This article is an edited version of a post that originally appeared on ‘Twitchy Woman’s Adventures with Parkinson’s’ and is re-published with the permission of Sharon Krischer. Read more of her blog here
Podcast: How can you speak the same language as your healthcare professional?
Physiotherapist Josefa Domingos opens up with her patient Idelta Oliveira
4 days ago
Is there a link between Parkinson’s disease and blood vessel dysfunction?
Scientists in Slovakia have investigated the link between blood vessel dysfunction and Parkinson’s – and found that dopamine agonists may have an impact. The team studied the function of the endothelium – a membrane which lines the heart and blood vessels and helps control blood fluidity – in 41 people with the condition and 41 people without. Endothelial function was then measured through a parameter that assessed how easily blood could flow through the vessels. The results showed that while more people with Parkinson’s had endothelial dysfunction compared to those without, the difference did not reach statistical significance. However, the researchers noted that the findings suggested “an association between smoking, dopamine agonists, and impaired endothelial function” in those with the condition. Outlining the study’s limitations, the team noted that more research is needed to explore this potential link.
New swab test may help with Parkinson’s disease diagnosis
Researchers at the University of Manchester, UK, have drawn on one woman’s sense of smell to develop a swab test that may be used to detect Parkinson’s. The scientists used the test to analyse sebum (a type of oily substance on the skin) in 79 people with Parkinson’s and a control group of 71 healthy individuals. The team identified more than 4,000 different compounds in the participant samples – including 500 that were unique to those living with the condition. The test was developed with the help of Joy Milne from Perth, Scotland, whose unique sense of smell meant that she noticed a change in her late husband Les’s odour twelve years before he was diagnosed with Parkinson’s. Speaking to the BBC, Professor Perdita Barran, who led the research, described the test as potentially “transformative” – and said that the team hopes to roll the test out to people in…
Could a national biobank help inform the future of Parkinson’s disease treatment in Australia?
A biobank is a collection of biological samples and data designed to be used for research. Now, researchers in Australia are working to build a biobank for Parkinson’s. As part of the project, the scientists are conducting scans of people that have been injected with fluorodopa – a substance that highlights dopamine in the brain. Participants include people living with Parkinson’s and a control group of people without the condition. The resulting database of scans will be used to create a national biobank that aims to inform treatment and research into the condition. Commenting on the study, Olivia Nasser – executive director at the Hospital Research Foundation, which is helping to fund the research – said, “Once we build up the biobank of scans, it can actually be used as an effective way to treat Parkinson’s.” The researchers encourage people with and without Parkinson’s to take part in the trial.